Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. engages in the distribution and sale of medical devices in China. The company offers vascular intervent...
China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%
INNOSTIC: The net profit for the third quarter was 92.7977 million yuan, a year-on-year increase of 49.14%
INNOSTIC: The company does not have brain-computer interface products or related technology reserves
INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms
On the first day of listing, the new stock of the Growth Enterprise Market, INNOSTIC, once rose over 500%, currently reported at 42.07 yuan/share
September 17th New Stock Reminder: Inovance Automotive announces online lottery results and payment, INNOSTIC announces winning rate